Cargando…
Classifying Medulloblastoma Subgroups Based on Small, Clinically Achievable Gene Sets
As treatment protocols for medulloblastoma (MB) are becoming subgroup-specific, means for reliably distinguishing between its subgroups are a timely need. Currently available methods include immunohistochemical stains, which are subjective and often inconclusive, and molecular techniques—e.g., NanoS...
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8223061/ https://www.ncbi.nlm.nih.gov/pubmed/34178626 http://dx.doi.org/10.3389/fonc.2021.637482 |